We are live on ! Find out more
GC

Grace Capital Portfolio holdings

AUM $168M
1-Year Est. Return 21.6%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
AUM
$168M
AUM Growth
+$5.88M
Cap. Flow
+$7.04M
Cap. Flow %
4.18%
Top 10 Hldgs %
32.21%
Holding
167
New
6
Increased
63
Reduced
19
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Healthcare 17.23%
3 Consumer Discretionary 9.91%
4 Financials 8.62%
5 Communication Services 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDY icon
151
Dr. Reddy's Laboratories
RDY
$10.5B
-15,000
Closed -$185K
ROKU icon
152
Roku
ROKU
$21.4B
-1,340
Closed -$420K
SE icon
153
Sea Limited
SE
$63.7B
-548
Closed -$175K
SRLN icon
154
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
-20,008
Closed -$918K
TIP icon
155
iShares TIPS Bond ETF
TIP
$14.5B
-6,908
Closed -$892K
VDC icon
156
Vanguard Consumer Staples ETF
VDC
$7.96B
-1,139
Closed -$204K
VFH icon
157
Vanguard Financials ETF
VFH
$13.4B
-2,705
Closed -$251K
VGSH icon
158
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
-7,300
Closed -$448K
VGT icon
159
Vanguard Information Technology ETF
VGT
$139B
-15,920
Closed -$799K
VHT icon
160
Vanguard Health Care ETF
VHT
$18B
-3,661
Closed -$905K
VNQ icon
161
Vanguard Real Estate ETF
VNQ
$39.6B
-8,614
Closed -$942K
VOX icon
162
Vanguard Communication Services ETF
VOX
$5.78B
-5,421
Closed -$763K
QVCGA
163
DELISTED
QVC Group Inc Series A
QVCGA
-400
Closed -$212K
XLRN
164
DELISTED
Acceleron Pharma
XLRN
-4,000
Closed -$695K

Similar funds

Grace Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Grace Capital held 167 positions worth $168M, up 3.6% from $163M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grace Capital deployed $7.04M of net new capital in Q4 2021, opening 6 new positions and adding to 63 existing holdings. Its largest new stake was Jasper Therapeutics: 21,811 shares worth $1.71M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Ares Capital, an estimated $415K trimmed.

  • Grace Capital's largest Q4 2021 buy was Jasper Therapeutics: 21,811 shares worth $1.71M.
  • Grace Capital added most to Vanguard Consumer Discretionary ETF in Q4 2021, an estimated $6.52M increase.
  • Grace Capital's biggest Q4 2021 reduction was Ares Capital, cutting an estimated $415K.
  • Grace Capital fully exited Vanguard Real Estate ETF in Q4 2021, selling an estimated $942K.
  • Grace Capital's ten largest holdings make up 32% of its $168M portfolio in Q4 2021.
  • Grace Capital opened 6 new positions and closed 24 in Q4 2021.
  • Grace Capital's portfolio value rose 3.6% quarter-over-quarter to $168M.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.